Hamburg Entrepreneur Revolutionizes Diagnostics with ‘Igloo’ Rapid Blood Test
Hamburg, March 4, 2026 – The COVID-19 pandemic has firmly established rapid testing as a standard in medicine. Now, a Hamburg-based entrepreneur is taking this concept further, demonstrating what can be measured with just a few drops of blood. Janneke Lupp, founder of the company goodscare, has developed a compact rapid testing device named ‘Igloo,’ poised to make advanced diagnostics more accessible.
The ‘Igloo’ device, designed for versatility, is intended for use in a variety of settings, including pharmacies, doctors’ offices, cruise ships, and even fitness studios. This broad application highlights its potential to bring convenient and quick health insights directly to consumers and professionals alike.
The Vision Behind ‘Igloo’
Janneke Lupp’s initiative with goodscare aims to simplify and accelerate diagnostic processes. The ‘Igloo’ device is capable of measuring a range of vital indicators, from detecting viruses to assessing vitamin levels and cholesterol, all from a minimal blood sample. This technological advancement promises to empower individuals and healthcare providers with immediate access to crucial health data, enabling quicker decisions and personalized health management.
The development of ‘Igloo’ comes at a time when there is a growing demand for on-the-spot diagnostic tools. The pandemic underscored the importance of rapid and reliable testing, and Lupp’s innovation builds upon this foundation, extending the capabilities of quick diagnostics beyond infectious diseases to broader health monitoring.
Applications and Impact
The strategic placement of ‘Igloo’ in pharmacies will allow for immediate health screenings, offering convenience for individuals seeking quick checks without a doctor’s appointment. For medical practitioners, it provides an efficient tool for preliminary assessments, potentially streamlining patient care and reducing wait times for lab results.
Its utility on cruise ships is particularly notable, where rapid testing can be crucial for managing health on board, especially in preventing the spread of illnesses among passengers and crew. Furthermore, integrating ‘Igloo’ into fitness studios could offer athletes and health enthusiasts immediate insights into their nutritional status and overall well-being, helping them optimize their training and diet.
The ‘Igloo’ device represents a significant step forward in making sophisticated diagnostic capabilities more pervasive and user-friendly. By enabling quick measurements of viruses, vitamins, and cholesterol, Janneke Lupp and goodscare are contributing to a future where health monitoring is more integrated into daily life, fostering a proactive approach to health management.
The Hamburg entrepreneur’s commitment to innovation in health technology underscores the city’s role as a hub for groundbreaking advancements. With ‘Igloo,’ Lupp is not just offering a product but a new paradigm for personal health diagnostics, making complex health information accessible and actionable for a wider audience.
The introduction of ‘Igloo’ is expected to generate considerable interest across the health and wellness sectors, signaling a new era for rapid and accessible health testing. As the device rolls out, its impact on public health and individual well-being will be closely watched.
